• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病的鉴别诊断-NKX2-1 相关疾病的神经学方面。

Differential diagnosis of Huntington's disease- neurological aspects of NKX2-1-related disorders.

机构信息

Student's Scientific Group, Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Department of Neurology, Faculty of Health Sciences, Medical University of Warsaw, Ludwika Kondratowicza 8, Warsaw, 03-242, Poland.

出版信息

J Neural Transm (Vienna). 2024 Sep;131(9):1013-1024. doi: 10.1007/s00702-024-02800-3. Epub 2024 Jun 25.

DOI:10.1007/s00702-024-02800-3
PMID:38916623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11365827/
Abstract

Benign hereditary chorea (BHC) is an inherited neurological disorder consisting of childhood-onset, nonprogressive chorea, generally without any other manifestations. In most reported cases, the inheritance of BHC is autosomal dominant but both incomplete penetrance and variable expressivity are observed and can be caused by NKX2-1 mutations. The spectrum contains choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress syndrome. The neurological symptoms can be misdiagnosed as Huntington's disease (HD). The two Polish families were diagnosed with NKX2-1 gene mutations and a literature review concerning the NKX2-1-related disorders was conducted. All family members were examined by experienced movement disorders specialists. PubMed database was searched to obtain previously described NKX2-1 cases. Whole exome sequencing (WES) was performed in one proband (Family A) and direct NKX2-1 sequencing in the second (Family B). Two Polish families were diagnosed with NKX2-1 gene mutations (p.Trp208Leu and p.Cys117Alafs*8). In one family, the co-occurrence of HD was reported. Forty-nine publications were included in the literature review and symptoms of 195 patients with confirmed NKX2-1 mutation were analyzed. The most common symptoms were chorea and choreiform movements, and delayed motor milestones. The NKX2-1 mutation should always be considered as a potential diagnosis in families with chorea, even with a family history of HD. Lack of chorea does not exclude the NKX2-1-related disorders.

摘要

良性遗传性舞蹈病(BHC)是一种遗传性神经系统疾病,其特征为儿童期发病、进行性不加重的舞蹈病,通常无其他表现。在大多数报道的病例中,BHC 的遗传方式为常染色体显性遗传,但存在不完全外显和表现度差异,可由 NKX2-1 突变引起。其表型谱包括舞蹈手足徐动症、先天性甲状腺功能减退症和新生儿呼吸窘迫综合征。神经症状可能被误诊为亨廷顿病(HD)。两个波兰家族被诊断为 NKX2-1 基因突变,并对 NKX2-1 相关疾病进行了文献复习。所有家族成员均由经验丰富的运动障碍专家进行检查。在一个先证者(家族 A)中进行了全外显子组测序(WES),在另一个先证者(家族 B)中进行了直接 NKX2-1 测序。两个波兰家族均被诊断为 NKX2-1 基因突变(p.Trp208Leu 和 p.Cys117Alafs*8)。在一个家族中,报告了 HD 的共病现象。文献复习共纳入 49 篇出版物,分析了 195 例经证实的 NKX2-1 突变患者的症状。最常见的症状是舞蹈病和舞蹈样运动,以及运动发育迟缓。即使有 HD 家族史,对于出现舞蹈病的家族,也应始终考虑 NKX2-1 突变作为潜在的诊断。无舞蹈病并不能排除 NKX2-1 相关疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/d0968def6a20/702_2024_2800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/ebcc8f2cb918/702_2024_2800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/e3648f5cc613/702_2024_2800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/d0968def6a20/702_2024_2800_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/ebcc8f2cb918/702_2024_2800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/e3648f5cc613/702_2024_2800_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2480/11365827/d0968def6a20/702_2024_2800_Fig3_HTML.jpg

相似文献

1
Differential diagnosis of Huntington's disease- neurological aspects of NKX2-1-related disorders.亨廷顿病的鉴别诊断-NKX2-1 相关疾病的神经学方面。
J Neural Transm (Vienna). 2024 Sep;131(9):1013-1024. doi: 10.1007/s00702-024-02800-3. Epub 2024 Jun 25.
2
A Systematic Review of the Huntington Disease-Like 2 Phenotype.亨廷顿舞蹈症样2型表型的系统评价
J Huntingtons Dis. 2017;6(1):37-46. doi: 10.3233/JHD-160232.
3
Therapeutic interventions for symptomatic treatment in Huntington's disease.亨廷顿舞蹈症症状治疗的干预措施。
Cochrane Database Syst Rev. 2009 Jul 8(3):CD006456. doi: 10.1002/14651858.CD006456.pub2.
4
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.NXK2-1 相关疾病舞蹈症药物治疗的系统评价:来自病例研究和系列研究的疗效和安全性证据。
Eur J Neurol. 2023 Dec;30(12):3928-3948. doi: 10.1111/ene.16038. Epub 2023 Sep 11.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
7
Permanent Neonatal Diabetes Mellitus永久性新生儿糖尿病
8
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
9
Therapeutic interventions for disease progression in Huntington's disease.亨廷顿舞蹈症疾病进展的治疗干预措施。
Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006455. doi: 10.1002/14651858.CD006455.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Systematic review of drug therapy for chorea in NXK2-1-related disorders: Efficacy and safety evidence from case studies and series.NXK2-1 相关疾病舞蹈症药物治疗的系统评价:来自病例研究和系列研究的疗效和安全性证据。
Eur J Neurol. 2023 Dec;30(12):3928-3948. doi: 10.1111/ene.16038. Epub 2023 Sep 11.
2
Altered pituitary morphology as a sign of benign hereditary chorea caused by TITF1/NKX2.1 mutations.因 TITF1/NKX2.1 突变导致的良性遗传性舞蹈病的垂体形态改变。
Neurogenetics. 2022 Apr;23(2):91-102. doi: 10.1007/s10048-021-00680-3. Epub 2022 Jan 25.
3
Working memory, attention and planning abilities in NKX2.1-related chorea.
NKX2.1 相关舞蹈症的工作记忆、注意力和计划能力。
Parkinsonism Relat Disord. 2021 Jul;88:24-27. doi: 10.1016/j.parkreldis.2021.05.021. Epub 2021 May 27.
4
Deletion of conserved non-coding sequences downstream from NKX2-1: A novel disease-causing mechanism for benign hereditary chorea.NKX2-1 下游保守非编码序列缺失:良性遗传性舞蹈病的一种新的致病机制。
Mol Genet Genomic Med. 2021 Apr;9(4):e1647. doi: 10.1002/mgg3.1647. Epub 2021 Mar 5.
5
Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.肺腺癌中三叶因子 1 和甲状腺转录因子 1 的相互表达。
Cancer Sci. 2020 Jun;111(6):2183-2195. doi: 10.1111/cas.14403. Epub 2020 Apr 30.
6
Levodopa-Responsive Chorea: A Review.左旋多巴反应性舞蹈症:综述
Ann Indian Acad Neurol. 2020 Mar-Apr;23(2):211-214. doi: 10.4103/aian.AIAN_221_19. Epub 2020 Feb 25.
7
Benign hereditary chorea: From benign to serious.良性遗传性舞蹈病:从良性到严重。
Rev Neurol (Paris). 2020 May;176(4):295-296. doi: 10.1016/j.neurol.2019.07.026. Epub 2020 Jan 23.
8
Haploinsufficiency of NKX2-1 in Brain-Lung-Thyroid Syndrome with Additional Multiple Pituitary Dysfunction.脑-肺-甲状腺综合征伴多发性垂体功能不全的 NKX2-1 单倍体不足。
Horm Res Paediatr. 2019;92(5):340-344. doi: 10.1159/000503683. Epub 2019 Nov 8.
9
Chiari Malformation Type I in a Patient with a Novel Mutation.一名患有新型突变的患者的I型Chiari畸形
J Pediatr Neurosci. 2019 Jul-Sep;14(3):169-172. doi: 10.4103/jpn.JPN_108_18. Epub 2019 Sep 27.
10
Chorea.舞蹈病
Continuum (Minneap Minn). 2019 Aug;25(4):1001-1035. doi: 10.1212/CON.0000000000000763.